Zevra Therapeutics (ZVRA) Return on Equity (2016 - 2025)
Historic Return on Equity for Zevra Therapeutics (ZVRA) over the last 10 years, with Q3 2025 value amounting to 0.28%.
- Zevra Therapeutics' Return on Equity rose 20400.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 20400.0%. This contributed to the annual value of 2.08% for FY2024, which is 14100.0% down from last year.
- Latest data reveals that Zevra Therapeutics reported Return on Equity of 0.28% as of Q3 2025, which was up 20400.0% from 0.03% recorded in Q2 2025.
- In the past 5 years, Zevra Therapeutics' Return on Equity registered a high of 0.28% during Q3 2025, and its lowest value of 2.28% during Q1 2025.
- Over the past 5 years, Zevra Therapeutics' median Return on Equity value was 0.08% (recorded in 2021), while the average stood at 0.61%.
- As far as peak fluctuations go, Zevra Therapeutics' Return on Equity plummeted by -21900bps in 2021, and later skyrocketed by 20400bps in 2025.
- Zevra Therapeutics' Return on Equity (Quarter) stood at 0.07% in 2021, then fell by -8bps to 0.07% in 2022, then plummeted by -945bps to 0.75% in 2023, then crashed by -158bps to 1.93% in 2024, then soared by 115bps to 0.28% in 2025.
- Its Return on Equity stands at 0.28% for Q3 2025, versus 0.03% for Q2 2025 and 2.28% for Q1 2025.